Skip to main content
Log in

CD44 adhesion molecule and neuro-glial proteoglycan NG2 as invasive markers of glioma

  • Published:
Brain Cell Biology

Abstract

Glioma invasion into the CNS involves the interaction of tumor cells with the host’s cells and extracellular matrix (ECM) molecules. In this study, the expression of ECM-associated and cell-associated proteins such as the transmembrane CD44 adhesion molecule and neuro-glial proteoglycan 2 (NG2), a member of the chondroitin sulfate proteoglycan family, were evaluated during glioma progression, in vitro and in vivo, using a model of a highly invasive and aggressive intracerebral mouse G-26 glioma. We found a marked increase in CD44 and NG2 expression in brain tissue containing glioma. The glioma levels of these proteins gradually increased over time to reach 3–15 times the levels in the contralateral control. NG2 and CD44 expression paralleled progression of the glioma, being higher on days 14 and 21 than on day 2 post-glioma implant. In addition, when invading glioma crossed the midline in the advanced tumor stage, levels of each of these proteins in the contralateral tissue were elevated, but were still significantly lower than in the ipsilateral, tumor-bearing hemisphere. Immunohistochemistry of advanced stage G-26 glioma (day 21) showed CD44 expression to be most prominent at the front of the glioma invasion line, sharply separated from normal brain parenchyma which expressed glial fibrillary acidic protein (GFAP). However, single CD44 positive cells that escaped the tumor mass penetrated between the astrocytes that encased the tumor at its periphery. In contrast, NG2 was expressed on nearly all glioma cells within the tumor mass but less so at the leading edge of the tumor. The NG2 positive cells were clearly demarcated and morphologically distinguishable from GFAP positive cells and only sporadic, small groups of NG2 positive cells were seen in the GFAP positive zone of the neuropil. Taken together, these data show that during glioma progression in the brain, the level and pattern of glioma-associated molecules such as CD44 and NG2 may aid in tracing and targeting the invading glioma cells.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

References

  • Al-Hajj, M., Wicha, M. S., Benito-Hernandez, A., Morrison, S. J., and Clarke, M. F. (2003). Prospective identification of tumorigenic breast cancer cells. Proc. Natl. Acad. Sci. U.S.A. 100, 3983–3988

    Article  PubMed  CAS  Google Scholar 

  • Ariza, A., Lopez, D., Mate, J. L., Isamat, M., Musulen, E., Pujol, M., Levy, A., and Navas-Palacios, J. J. (1995). Role of CD44 in the invasiveness of glioblastoma multiforme and the noninvasiveness of meningioma: An immunohistochemistry study. Human Pathol. 26, 1144–1147

    Article  CAS  Google Scholar 

  • Bellail, A. C., Hunter, S. B., Brat, D. J., Tan, C., and Van Meir, E. G. (2004). Microregional extracellular matrix heterogeneity in brain modulates glioma cell invasion. Int. J. Biochem. Cell Biol. 36, 1046–1069

    Article  PubMed  CAS  Google Scholar 

  • Burg, M. A., Grako, K. A., and Stallcup W. B. (1998). Expression of the NG2 proteoglycan enhances the growth and metastatic properties of melanoma cells. J. Cell. Physiol. 177, 299–312

    Article  PubMed  CAS  Google Scholar 

  • Burg, M. A., Nishiyama, A., and Stallcup, W. B. (1997). A central segment of the NG2 proteoglycan is critical for the ability of glioma cells to bind and migrate toward type VI collagen. Exp. Cell Res. 235, 254–264

    Article  PubMed  CAS  Google Scholar 

  • Butt, A. M., Kiff, J., Hubbard, P., and Berry, M. (2002). Synantocytes: New functions for novel NG2 expressing glia. J. Neurocytol. 31, 551–565

    Article  PubMed  CAS  Google Scholar 

  • Chekenya, M., and Pilkington, G. J. (2002). NG2 precursor cells in neoplasia: Functional, histogenesis and therapeutic implications for malignant brain tumors. J. Neurocytol. 31, 507–521

    Article  PubMed  CAS  Google Scholar 

  • Chekenya, M., Rooprai, H. K., Davies, D., Levine, J. M., Butt, A. M., and Pilkington, G. J. (1999). The NG2 chondroitin sulfate proteoglycan: Role in malignant progression of human brain tumors. Int. J. Dev. Neurosci. 17, 421–435

    Article  PubMed  CAS  Google Scholar 

  • Chintala, S. K., Sawaya, R., Gokaslan, Z. L., Fuller, G., and Rao, J. S. (1996). Immunohistochemical localization of extracellular matrix proteins in human glioma, both in vivo and in vitro. Cancer Lett. 101, 107–114

    Article  PubMed  CAS  Google Scholar 

  • Chittajallu, R., Aguirre, A., and Gallo, V. (2004). NG2-positive cells in the mouse white and grey matter display distinct physiological properties. J. Physiol. 561, 109–122

    Article  PubMed  CAS  Google Scholar 

  • Doane, K. J., Howell, S. J., and Birk, D. E. (1998). Identification and functional characterization of two type VI collagen receptors, alpha 3 beta 1 integrin and NG2, during avian corneal stromal development. Invest. Ophthalmol. Visual Sci. 39, 263–275

    CAS  Google Scholar 

  • Faassen, A. E., Schrager, J. A., Klein, D. J., Oegema, T. R., Couchman, J. R., and McCarthy, J. B. (1992). A cell surface chondroitin sulfate proteoglycan, immunologically related to CD44, is involved in type I collagen-mediated melanoma cell motility and invasion. J. Cell Biol. 116, 521–531

    Article  PubMed  CAS  Google Scholar 

  • Fang, X., Burg, M. A., Barritt, D., Dahlin-Huppe, K., Nishiyama, A., and Stallcup, W. B. (1999). Cytoskeletal reorganization induced by engagement of the NG2 proteoglycan leads to cell spreading and migration. Mol. Biol. Cell 10, 3373–3387

    PubMed  CAS  Google Scholar 

  • Fidler, P. S., Schuette, K., Asher, R. A., Dobbertin, A., Thornton, S. R., Calle-Patino, Y., Muir, E., Levine, J. M., Geller, H. M., Rogers, J. H., Faissner, A., and Fawcett, J. W. (1999). Comparing astrocytic cell lines that are inhibitory or permissive for axon growth: The major axon-inhibitory proteoglycan is NG2. J. Neurosci. 19, 8778–8788

    PubMed  CAS  Google Scholar 

  • Galli, R., Binda, E., Orfanelli, U., Cipelletti, B., Gritti, A., De Vitis, S., Fiocco, R., Foroni, C., Dimeco, F., and Vescovi, A. (2004). Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma. Cancer Res. 64, 7011–7021

    Article  PubMed  CAS  Google Scholar 

  • Gladson, C. L. (1999). The extracellular matrix of gliomas: Modulation of cell function. J. Neuropathol. Exp. Neurol. 10, 1029–1040

    Google Scholar 

  • Hibino S., Shibuya, M., Engbring, J. A., Mochizuki, M., Nomizu, M., and Kleinman, H. K. (2004). Identification of an active site on the laminin alpha5 chain globular domain that binds to CD44 and inhibits malignancy. Cancer Res. 64, 4810–4816

    Article  PubMed  CAS  Google Scholar 

  • Hibino S, Shibuya, M., Hoffman, M. P., Engbring, J.A., Hossain, R., Mochizuki, M., Kudoh, S., Nomizu, M., and Kleinman, H. K. (2005). Laminin alpha5 chain metastasis- and angiogenesis-inhibiting peptide blocks fibroblast growth factor 2 activity by binding to the heparan sulfate chains of CD44. Cancer Res. 65, 10494–10501

    Article  PubMed  CAS  Google Scholar 

  • Johansson, F. K., Goransson, H., and Westermark, B. (2005). Expression analysis of genes involved in brain tumor progression driven by retroviral insertional mutagenesis in mice. Oncogene 24, 3896–3905

    Article  PubMed  CAS  Google Scholar 

  • Jones, L. L., Yamaguchi, Y., Stallcup, W. B., and Tuszynski, M. (2002). NG2 is a major chondroitin sulfate proteoglycan produced after spinal cord injury and is expressed by macrophages and oligodendrocyte progenitors. J. Neurosci. 22, 2792–2803

    PubMed  CAS  Google Scholar 

  • Kawashima, H., Hirose, M., Hirose, J., Nagakubo, D., Plaas, A. H. K., and Miyasaka, M. (2000). Binding of a large chondroitin sulfate/dermatan sulfate proteoglycan, versican, to L-selectin, P-selectin, and CD44. J. Biol. Chem. 275, 35448–35456

    Article  PubMed  CAS  Google Scholar 

  • Khoshyomn, S., Penar, P. L., Wadsworth, M. P., and Taatjes, D. J. (1997). Localization of CD44 at the invasive margin of glioblastomas by immunoelectron microscopy. Ultrastract. Pathol. 21, 517–525

    CAS  Google Scholar 

  • Kim, M.-S., Park, M.-J., Moon, E.-J., Kim, S.-J., Lee, C.-H., Yoo, H., Shin, S.-H., Song, E.-S., and Lee, S.-H. (2005). Hyaluronic acid induces osteopontin via the phosphatidylinositol 3-Kinase/Akt pathway to enhance motility of human glioma cells. Cancer Res. 65, 686–691

    PubMed  CAS  Google Scholar 

  • Knott, J. C., Mahesparan, R., Garcia-Cabrera, I., Bolge Tysnes, B., Edvardsen, K., Ness, G. O., Mork, S., Lund-Johansen, M., and Bjerkvig, R. (1998). Stimulation of extracellular matrix components in the normal brain by invading glioma cells. Int. J. Cancer 75, 864–872

    Article  PubMed  CAS  Google Scholar 

  • Knutson, J. R., Iida, J., Fields, G. B., and McCarthy, J. B. (1996). CD44/chondroitin sulfate proteoglycan and alpha 2 beta 1 integrin mediate human melanoma cell migration on type IV collagen and invasion of basement membranes. Mol. Biol. Cell 7, 383–396

    PubMed  CAS  Google Scholar 

  • Levine, J. M. (1994). Increased expression of the NG2 chondroitin-sulfate proteoglycan after brain injury. J. Neurosci. 14, 4716–4730

    PubMed  CAS  Google Scholar 

  • Levine, J. M., and Card, J. P. (1987). Light and electron microscopic localization of a cell surface antigen (NG2) in the rat cerebellum: Association with smooth protoplasmic astrocytes. J. Neurosci. 7, 2711–2720

    PubMed  CAS  Google Scholar 

  • Levine, J. M., and Nishiyama, A. (1996). The NG2 chondroitin sulfate proteoglycan: A multifunctional proteoglycan associated with immature cells. Prespects Dev. Biol. 3, 245–259

    CAS  Google Scholar 

  • Li, H., Liu, J., and Hofmann, M. (1995). Differential CD44 expression patterns in primary brain tumors and brain metastases. Br. J. Cancer 72, 160–163

    PubMed  CAS  Google Scholar 

  • Lin, H.-X., Dahlin-Huppe, K., and Stallcup, W. B. (1996a). Interaction of the NG2 proteoglycan with the actin cytoskeleton. J. Cell Biochem. 63, 463–477

    Article  PubMed  CAS  Google Scholar 

  • Lin, X.-H., Grako, K. A., Burg, M. A., and Stallcup, W. B. (1996b). NG2 proteoglycan and the actin binding protein fascin define separate populations of actin-containing filopodia and lamellipodia during cell spreading and migration. Mol. Biol. Cell 7, 1977–1993

    PubMed  CAS  Google Scholar 

  • Mahesparan, R., Read, T.-A., Lund-Johansen, M., Skaftnesmo, K. O., Bjerkvig, R., and Engebraaten, O. (2003). Expression of extracellular matrix components in a highly infiltrative in vivo glioma model. Acta Neuropathol. 105, 49–57

    PubMed  CAS  Google Scholar 

  • McKeever, P. E., Fligliel, S. E., Varani, J., Hudson, J. L., Smith, D., Castle, R. L., and McCoy, J. P. (1986). Products of cells cultured from gliomas. IV. Extracellular matrix proteins of gliomas. Int. J. Cancer 37, 867–874

    Article  PubMed  CAS  Google Scholar 

  • Murai, T., Miyazaki, Y., Nishinakamura, H., Sugahara, K. N., Miyauchi, T., Sako, Y., Yanagida, T., and Miyasaka, M. (2004). Engagement of CD44 promotes Rac activation and CD44 cleavage during tumor cell migration. J. Biol. Chem. 279, 4541–4550

    Article  PubMed  CAS  Google Scholar 

  • Nishiyama, A., Lin, X.-H., Giese, N., Heldin, C. H., and Stallcup, W. B. (1996). Co-localization of NG2 proteoglycan and PDGF alpha receptor on O2A progenitor cells in the developing rat brain. J. Neurosci. 43, 299–314

    Article  CAS  Google Scholar 

  • Nishiyama, A., and Stallcup, W. B. (1993). Expression of NG2 proteoglycan causes retention of type VI collagen on the cell surface. Mol. Biol. Cell 4, 1097–1108

    PubMed  CAS  Google Scholar 

  • Pedersen, P. H., Marienhagen, K., Mork S., and Bjerkvig, R. (1993). Migratory pattern of fetal rat brain cells and human glioma cells in the adult rat brain. Cancer Res. 53, 5158–5165

    PubMed  CAS  Google Scholar 

  • Radotra, B., McCormick D., and Crockard, A. (1994). CD44 plays a role in adhesive interactions between glioma cells and extracellular matrix components. Neuropathol. Appl. Neurobiol. 20, 399–405

    Article  PubMed  CAS  Google Scholar 

  • Ranuncolo, S. M., Ladeda, V., Specterman, S., Varela, M., Lastiri, J., Morandi, A., Matos, E., Bal de Kier Joffe, E., Puricelli, L., and Pallotta, M. G. (2002). CD44 expression in human gliomas. J. Surg. Oncol. 79, 30–36

    Article  PubMed  CAS  Google Scholar 

  • Rezajooi, K., Pavlides, M., Winterbottom, J., Stallcup, W. B., Hamlyn, P. J., Lieberman, A. R., and Anderson, P. N. (2004). NG2 proteoglycan expression in the peripheral nervous system: Upregulation following injury and comparison with CNS lesions. Mol. Cell. Neurosci. 25, 572–584

    Article  PubMed  CAS  Google Scholar 

  • de Ridder, L. I., Laerum, O. D., Mork, S. J., and Bigner, D. D. (1987). Invasiveness of human glioma cell lines in vitro: Relation to tumorigenicity in athymic mice. Acta Neuropathol. 72, 207–213

    Article  PubMed  Google Scholar 

  • Rutka, J. T., Ackerley, C., Hubbard, S. L., Tilup, A., Dirks, P. B., Jung, S., Ivanchuk, S., Kurimoto, M., Tsugu, A, and Becker, L. E. (1998). Characterization of glial filament-cytoskeletal interactions in human astrocytomas: An immuno-ultrastructural analysis. Eur. J. Cell Biol. 76, 279–287

    PubMed  CAS  Google Scholar 

  • Schrappe, M., Klier, G. F., Spiro, R. C., Waltz, T. A., Reisfeld, R. A., Gladson, C. L. (1991). Correlation of chondroitin sulfate proteoglycan expression on proliferating brain capillary endothelial cells with the malignant phenotype of astroglial cells. Cancer Res. 51, 4986–4993

    PubMed  CAS  Google Scholar 

  • Shoshan, Y., Nishiyama, A., Chang, A., Mork, S., Barnett, G. H., Cowell, J. K., Trapp, B. D., and Staugaitis, S. M. (1999). Expression of oligodendrocyte progenitor cell antigens by gliomas: Implications for the histogenesis of brain tumors. Proc. Natl. Acad. Sci. USA 96, 10361–10366

    Google Scholar 

  • Stallcup, W. B., Beasley, L., and Levine, J. M. (1983). Cell-surface molecules that characterize different stages in the development of cerebral interneurons. Cold Spring Harbor Symp. Quant. Biol. 48, 761–774

    PubMed  CAS  Google Scholar 

  • Stallcup, W. B., Dahlin, K., and Healy, P. (1990). Interaction of the NG2 chondroitin sulfate proteoglycan with type VI collagen. J. Cell Biol. 111, 3177–3188

    Article  PubMed  CAS  Google Scholar 

  • Stylli, S. S., Kaye, A. H., and Novak, U. (2000). Induction of CD44 expression in stab wounds of brain: Long term persistence of CD44 expression. J. Clin. Neurosci. 7, 137–140

    Article  PubMed  CAS  Google Scholar 

  • Tillet, E., Gential, B., Garrone, R., and Stallcup, W. B. (2002). NG2 proteoglycan mediates beta 1 integrin-independent cell adhesion and spreading on collagen VI. J. Cell Biochem. 86, 726–736

    Article  PubMed  CAS  Google Scholar 

  • Tysnes, B. B., Mahesparan, R., Thorsen, F., Haugland, H. K., Porwol, T., Enger, P. O., Lund-Johansen, M., and Bjerkvig, R. (1999). Laminin expression by glial fibrillary acidic protein positive cells in human gliomas. Int. J. Dev. Neurosci. 17, 531–539

    Article  PubMed  CAS  Google Scholar 

  • Wiranowska, M., Gonzalvo, A. A., Saporta, S., Gonzalez O. R., and Prockop, L. D. (1992). Evaluation of blood-brain barrier permeability and the effect of interferon in mouse glioma model. J. Neuro-Oncol. 14, 225–236

    Article  CAS  Google Scholar 

  • Wiranowska, M., and Naidu, A. K. (1994). Interferon effect on glycosaminoglycans in mouse glioma in vitro. J. Neuro-Oncol. 18, 9–17

    Article  CAS  Google Scholar 

  • Wiranowska, M, Prockop, L. D., Naidu, A. K., Saporta, S., Kori, S., and Kulkarni, A. (1994). Interferon entry through the blood-brain barrier in glioma and its effect on lipoxygenase activity. Anticancer Res. 14, 1121–1126

    PubMed  CAS  Google Scholar 

  • Wiranowska, M., Rojiani, A., Gottschall, P., Moscinski, L., Johnson, J., and Saporta, S. (2000). CD44 expression and MMP-2 secretion by glioma cells: Effect of interferon and anti-CD44 antibody. Anticancer Res. 20, 4301–4306

    PubMed  CAS  Google Scholar 

  • Wiranowska, M., Tresser, N., and Saporta, S. (1998). The effect of interferon and anti-CD44 antibody on mouse glioma invasiveness in vitro. Anticancer Res. 18, 3331–3338

    PubMed  CAS  Google Scholar 

  • Yamaguchi, Y. (2000). Lecticans: Organizers of the brain extracellular matrix. Cell. Mol. Life Sci. 57, 276–289

    Article  PubMed  CAS  Google Scholar 

  • Yuan, W., Matthews, R. T., Sandy, J., and Gottschall, P. E. (2002). Association between protease-specific proteolytic cleavage of brevican and synaptic loss in the dentate gyrus of kainic acid treated rats. Neurosicience 114, 1091–1101

    CAS  Google Scholar 

  • Zheng, Z., Katoh, S., He, Q., Oritani, K., Miyake, K., Lesley, J., Hyman, R., Hamik, A., Parkhouse, R. M., Farr, A. G., and Kincade, P. W. (1995). Monoclonal antibodies to CD44 and their influence on hyaluronan recognition. J. Cell Biol. 130, 485–495.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgment

This study was supported by a grant from the American Cancer Society Florida Division.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Marzenna Wiranowska.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wiranowska, M., Ladd, S., Smith, S.R. et al. CD44 adhesion molecule and neuro-glial proteoglycan NG2 as invasive markers of glioma. Brain Cell Bio 35, 159–172 (2006). https://doi.org/10.1007/s11068-007-9009-0

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11068-007-9009-0

Keywords

Navigation